Safety endpoints included the number of treatment-emergent adverse events and serious adverse events, assessed between baseline and week 111
In 2026, the 1st Circuit upheld dismissal of class actions challenging weight-loss drug exclusions under Section 1557 (e.g., Holland v
By microdosing GLP-1 medications, it may be possible to keep the frequency and intensity of side effects low while still receiving therapeutic benefits from the drugs
Key Takeaways Retatrutide is a once-weekly injectable triple agonist targeting GLP-1, GIP, and glucagon receptors Starting dose is typically 1 mg weekly, titrating up gradually to minimize side effects Maintenance doses range from 8 mg to 12 mg weekly based on individual response Titration is critical for balancing weight loss efficacy with tolerability Clinical trials show significant weight reduction compared to placebo Always work with a healthcare provider to determine your optimal dosing schedule Overview of Retatrutide What is Retatrutide
Novo Nordisk also has a savings program to help with your out-of-pocket costs
Who Is Each Medication Best For Choosing between retatrutide vs Mounjaro depends on several personal factors
